Unnaplast with Calamine

Manufacturer
Pharmaplast SAE
Effective date
2021-02-17
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 22:49:57

Label at a glance#

ProductUnnaplast with Calamine
Active ingredientZINC OXIDE, FERRIC OXIDE RED
Label structure8 sections

Indications and uses

Unnaplast ® used in the treatment of Venous stasis ulcers, some selected eczematous eruptions, lymphatic edema, thrombophlebitis, minor fractures, sports injuries, sprains and strains and burns.

Dosage and administration

1. Position the patient’s leg in a slightly flexed position. 2. Apply Unnaplast ® in a circular motion from the foot to the knee. The wrap should be snug but not tight. To cover the area completely, be sure each turn overlaps the previous one by half the bandage’s width. 3. Continue wrapping the patient’s leg up to the knee, using firm even pressure. Mold the boot with your free hand as you apply the bandage to ma...

Label contents#

Full prescribing information#

Active ingredient:

OTC - ACTIVE INGREDIENT SECTION

• Zinc Oxide 10% • Calamine 0.50%

Purpose:

OTC - PURPOSE SECTION

Skin Protectant

Uses:

INDICATIONS & USAGE SECTION

Unnaplast® used in the treatment of Venous stasis ulcers, some selected eczematous eruptions, lymphatic edema, thrombophlebitis, minor fractures, sports injuries, sprains and strains and burns.

Warnings:

WARNINGS SECTION

• Reuse of the product increases risk of infection.
• Dispose carefully in a manner preventing cross-contamination.
• For external use only.
• Do not make reverse turns while wrapping Unnaplast® bandage.
• Do not use if you are hypersensitive to the product or any of its components.
• Do not use on grossly macerated skin.
• If condition worsens or does not improve within 7 days, consult a doctor.
• Avoid contact with eyes.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

• Keep out of reach of children.

Directions:

DOSAGE & ADMINISTRATION SECTION

1. Position the patient’s leg in a slightly flexed position.
2. Apply Unnaplast® in a circular motion from the foot to the knee. The wrap should be snug but not tight. To cover the area completely, be sure each turn overlaps the previous one by half the bandage’s width.
3. Continue wrapping the patient’s leg up to the knee, using firm even pressure. Mold the boot with your free hand as you apply the bandage to make it smooth.
4. Apply an elastic or cohesive bandage to secure dressing and maintain compression.

Inactive ingredients:

INACTIVE INGREDIENT SECTION

• Carboxymethylcellulose
• Glycerol
• Purified water

SPL UNCLASSIFIED SECTION

Open weave cotton bandage with zinc oxide paste.

Pharmaplast

Made of open weave, light weight, finished selvage edges, cotton bandage impregnated with creamy zinc oxide paste with calamine.

Pharmaplast S.A.E.

Amria, free zone 23512,
Alexandria, Egypt
www.pharmaplast-online.com

Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PackagingPackaging

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
28691-100528691-1005-1, 28691-1005-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1517fa8f-811e-4199-99fa-acce0f58d087a14480ef-a816-4d13-b919-d33cc8a84b442023-04-14WarningsExact identifier
spl set id: a14480ef-a816-4d13-b919-d33cc8a84b44

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.